CSLHAM:CSJ +0.07%73 Forward Dividend Yield % is 3.62% as of Jun. 24, 2026. GuruFocus rates HAM:CSJ with a GF Score™ of 73/100 and a GF Value™ of €170.71 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 147 Biotechnology companies, CSL ranks better than 74.15% on this metric.
As of today (2026-06-24), the Forward Annual Dividend Yield of CSL is 3.62%.
As of today (2026-06-24), the Trailing Annual Dividend Yield of CSL is 3.62%.
HAM:CSJ's Forward Dividend Yield % is ranked better than 74.15% of 147
companies
in the Biotechnology industry
Industry Median: 1.51
vs HAM:CSJ: 3.62
During the past 12 months, CSL's average Dividends Per Share Growth Rate was -34.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 11.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 9.80% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 11.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of CSL was 42.20% per year. The lowest was 6.60% per year. And the median was 15.45% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
HAM:CSJ vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, CSL's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSL Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CSL's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where CSL's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
CSL Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 1.809829
2026-03-10
2026-03-11
2026-04-09
Cash Dividend
semi-annually
AUD:EUR 0.607018
AUD 2.450832
2025-09-09
2025-09-10
2025-10-03
Cash Dividend
semi-annually
AUD:EUR 0.562005
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
CSL's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
2.197197559844
/
68.23
=
3.22 %
Current Share Price is €68.23. CSL's Dividends per Share for the forward twelve months is calculated as €1.098598779922 * 2 = €2.197197559844.
CSL's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
2.475978618082
/
68.23
=
3.63 %
Current Share Price is €68.23. CSL's Dividends per Share for the trailing twelve months (TTM) ended in Today is €2.475978618082.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 3.62% mean?
CSL (HAM:CSJ) has a Forward Dividend Yield % of 3.62% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on CSL and its competitors. According to the industry distribution chart, CSL ranks #38 out of 147 companies in the Biotechnology industry, placing it in the top 25.9%.
Is CSL's Forward Dividend Yield % too high?
CSL's current Forward Dividend Yield % is 3.62%. The Biotechnology industry median Forward Dividend Yield % is 1.51. CSL's value of 3.62% is 139.7% above this industry median. Based on the distribution chart, CSL ranks #38 out of 147 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CSL has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CSL's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CSL ranks #38 out of 147 companies for Forward Dividend Yield %. This puts CSL in the upper half of its industry. The industry median Forward Dividend Yield % is 1.51. CSL's value of 3.62% is 139.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.51, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSL's current Forward Dividend Yield % of 3.62% is 139.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on CSL and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSL's current Forward Dividend Yield % is 3.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSL stock overvalued right now?
Based on GuruFocus' analysis, CSL (HAM:CSJ) is currently considered Significantly Undervalued. The stock's GF Value™ is €170.71, compared to a current price of €68.23 — trading 60% below its estimated fair value. The current Forward Dividend Yield % is 3.62% and 139.7% above the Biotechnology industry median of 1.51. CSL's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For CSL (HAM:CSJ), the current Forward Dividend Yield % is 3.62% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSL (HAM:CSJ) Overvalued in 2026?
Based on GuruFocus' analysis, CSL stock appears to be undervalued.
The current stock price of €68.23 is trading 60% below its estimated GF Value™ of €170.71.
GuruFocus considers CSL to be Significantly Undervalued.
Key valuation signals for HAM:CSJ:
Forward Dividend Yield %: 3.62%
GF Value™: €170.71 vs. price of €68.23 (60% below fair value)
Industry Position: 139.7% above the Biotechnology median (#38 of 147)
No single metric tells the full story. See the HAM:CSJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
73GF Score
Get the complete analysis for HAM:CSJ
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:CSJ has been successfully added to your 